Research progress on the relationship between the "gut-skin axis" and the uremic skin lesions

doi:10.3877/cma.j.issn.2095-3216.2023.05.010

Abstract

Abstract:

The skin lesion is one of the common complications in patients with uremia, and their pathogenesis has not been fully elucidated. Recent studies have shown that there is a close relationship between the gut and skin lesions in that they both interact and influence each other, forming the "gut-skin axis" . This article reviewed the research progress on the relationship between the "gut-skin axis" and uremic skin lesions so as to explore the potential therapeutic methods.

Key words: Gut-skin axis, Uremia, Skin lesions, Gut microbiota

Xiaomei Qiao, Kaili Kong, Jingai Fang, Xiaodong Zhang. Research progress on the relationship between the "gut-skin axis" and the uremic skin lesions[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(05): 291-294.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2023.05.010

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2023/V12/I05/291

Figures/Tables 1

References 34

[1]	Kuypers DR. Skin problems in chronic kidney disease [J]. Nat Clin Pract Nephrol, 2009, 5(3): 157-170.
[2]	De Pessemier B, Grine L, Debaere M, et al. Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions [J]. Microorganisms, 2021, 9(2): 353.
[3]	Sikora M, Stec A, Chrabaszcz M, et al. Gut microbiome in psoriasis: an updated review [J]. Pathogens, 2020, 9(6): 463.
[4]	Arck P, Handjiski B, Hagen E, et al. Is there a 'gut-brain-skin axis’？ [J]. Exp Dermatol, 2010, 19(5): 401-405.
[5]	Rysz J, Franczyk B, Ławiński J, et al. The impact of CKD on uremic toxins and gut microbiota [J]. Toxins (Basel), 2021, 13(4): 252.
[6]	Hedin C, Sonkoly E, Eberhardson M, et al. Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach [J]. J Intern Med, 2021, 290(2): 257-278.
[7]	O′Neill CA, Monteleone G, McLaughlin JT, et al. The gut-skin axis in health and disease: a paradigm with therapeutic implications [J]. Bioessays, 2016, 38(11): 1167-1176.
[8]	Alvarez-Payares JC, Ramírez-Urrea S, Correa-Parra L, et al. Mucocutaneous manifestations of inflammatory bowel disease [J]. Cureus, 2021, 13(8): e17191.
[9]	Codoñer F, Ramírez-Bosca A, Climent E, et al. Gut microbial composition in patients with psoriasis [J]. Sci Rep, 2018, 8(1): 3812.
[10]	Schricker S, Kimmel M. Unravelling the pathophysiology of chronic kidney disease-associated pruritus [J]. Clin Kidney J, 2021, 14(Suppl 3): i23-i31.
[11]	Daraghmeh M, Badran M, Janajreh A, et al. Prevalence of pruritus associated with hemodialysis and its association with sleep quality among hemodialysis patients: a multicenter study [J]. BMC Nephrol, 2022, 23(1): 213.
[12]	Moon SJ, Kim HJ, Cho SB, et al. Epidermal proteinase-activated receptor-2 expression is increased in end-stage renal disease patients with pruritus: a pilot study [J]. Electrolyte Blood Press, 2014, 12(2): 74-79.
[13]	Lin YT, Wu PH, Liang SS, et al. Protein-bound uremic toxins are associated with cognitive function among patients undergoing maintenance hemodialysis [J]. Sci Rep, 2019, 9(1): 20388.
[14]	Hu T, Wang B, Liao X, et al. Clinical features and risk factors of pruritus in patients with chronic renal failure [J]. Exp Ther Med, 2019, 18(2): 964-971.
[15]	Swarna S, Aziz K, Zubair T, et al. Pruritus associated with chronic kidney disease: a comprehensive literature review [J]. Cureus, 2019, 11(7): e5256.
[16]	宋娜，王菊. 甲状旁腺切除术对血液透析患者皮肤瘙痒的影响[J]. 实用医药杂志，2021, 38(5): 429-431.
[17]	Wala-Zielińska K, Swierczyńska-Mróz K, Krajewski P, et al. Elevated level of serum neurotrophin-4, but not of brain-derived neurotrophic factor, in patients with chronic kidney disease-associated pruritus [J]. J Clin Med, 2022, 11(21): 6292.
[18]	Blaha T, Nigwekar S, Combs S, et al. Dermatologic manifestations in end stage renal disease [J]. Hemodial Int, 2019, 23(1): 3-18.
[19]	Su X, Zhao Y, Li Y, et al. Gut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis [J]. Clin Sci (Lond), 2020, 134(12): 1521-1535.
[20]	Szepietowski JC, Reich A, Schwartz RA. Uraemic xerosis [J]. Nephrol Dial Transplant, 2004, 19(11): 2709-2712.
[21]	Goel V, Sil A, Das A. Cutaneous manifestations of chronic kidney disease, dialysis and post-renal transplant: a review [J]. Indian J Dermatol, 2021, 66(1): 3-11.
[22]	Batchelor E, Kapitsinou P, Pergola P, et al. Iron deficiency in chronic kidney disease: updates on pathophysiology, diagnosis, and treatment [J]. J Am Soc Nephrol, 2020, 31(3): 456-468.
[23]	Das NK, Schwartz AJ, Barthel G, et al. Microbial metabolite signaling is required for systemic iron homeostasis [J]. Cell Metab, 2020, 31(1): 115-130.
[24]	Kim S, Zhang X, Cho S, et al. Uremic solutes of indoxyl sulfate and p-cresol enhance protease-activated receptor-2 expression in vitro and in vivo in keratinocytes [J]. Hum Exp Toxicol, 2021, 40(1): 113-123.
[25]	Ahmed M, Zakir A, Ahsraf M, et al. Chronic kidney disease and calciphylaxis: a literature review [J]. Cureus, 2018, 10(9): e3334.
[26]	Nigwekar SU, Solid CA, Ankers E, et al. Quantifying a rare disease in administrative data: the example of calciphylaxis [J]. J Gen Intern Med, 2014, 29(Suppl 3): S724-S731.
[27]	Lopes R, Balbino KP, Jorge MP, et al. Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre/probiotics in chronic kidney disease: a systematic review [J]. Nutr Hosp, 2018, 35(3): 722-730.
[28]	Ureña Torres P, Souberbielle J, Solal M. Bone fragility in chronic kidney disease stage 3 to 5: the use of vitamin d supplementation [J]. Metabolites, 2022, 12(3): 266.
[29]	刘书馨，吴雨林，肖佳. 维持性血液透析患者甲状旁腺全切术后发生皮肤及内脏钙化防御复发一例及文献复习[J/CD]. 中华肾病研究电子杂志，2020, 9(2): 92-95.
[30]	Singh P, Rawat A, Alwakeel M, et al. The potential role of vitamin d supplementation as a gut microbiota modifier in healthy individuals [J]. Sci Rep, 2020, 10(1): 21641.
[31]	Basavaiah R, Gurudutt PS. Prebiotic carbohydrates for therapeutics [J]. Endocr Metab Immune Disord Drug Targets, 2021, 21(2): 230-245.
[32]	Hobby GP, Karaduta O, Dusio GF, et al. Chronic kidney disease and the gut microbiome [J]. Am J Physiol Renal Physiol, 2019, 316(6): F1211-F1217.
[33]	Yang H, Feng P, Xu Y, et al. The role of dietary fiber supplementation in regulating uremic toxins in patients with chronic kidney disease: a meta-analysis of randomized controlled trials [J]. J Ren Nutr, 2021, 31(5): 438-447.
[34]	Agarwal P, Garg V, Karagaiah P, et al. Chronic kidney disease-associated pruritus [J]. Toxins (Basel), 2021, 13(8): 527.

Please choose a citation manager

Content to export